Prepare for your visit

Eryn Thomas

Nurse Practitioner · Du Bois, PA · NPI 1467207183

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$2,067.12

in general payments reported to CMS, 2019-2025 · $1,384 in 2025

The $1,384 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

Who reported paying

General payments only, top 6 by amount.

Astrazeneca Pharmaceuticals LP $552.19
Glaxosmithkline, LLC. $505.78
Verona Pharma, INC. $207.83
Genzyme Corporation $165.63
Actelion Pharmaceuticals US, INC. $147.45
Regeneron Healthcare Solutions, INC. $139.58

Drugs and devices associated with these payments

Nucala Dupixent Airsupra Ohtuvayre Tezspire Uptravi Breztri Fisher & Paykel Healthcare Opsumit Trelegy Ellipta Fasenra Ofev

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Eryn Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11614583/eryn-thomas